Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapy

著录项

• 来源
  《Future oncology》 |2020年第5期|共6页
• 作者

  Alessia Cimadamore; Antonio Lopez-Beltran; Francesco Massari; Matteo Santoni; Roberta Mazzucchelli; Marina Scarpelli; Andrea B Galosi; Liang Cheng; Rodolfo Montironi;

  展开▼
• 作者单位

  Department of Pathological Anatomy Polytechnic University of the Marche Region School of Medicine;

  Department of PathologyandSurgery Faculty of Medicine;

  Department of Oncology S. Orsola-Malpighi Hospital;

  Department of Oncology Macerata Hospital;

  Department of Pathological Anatomy Polytechnic University of the Marche Region School of Medicine;

  Department of Pathological Anatomy Polytechnic University of the Marche Region School of Medicine;

  Department of Urology Polytechnic University of the Marche Region United Hospitals;

  Department of PathologyandLaboratory Medicine Indiana University School of Medicine;

  Department of Pathological Anatomy Polytechnic University of the Marche Region School of Medicine;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词

  BRCA1; BRCA2; defective DNA repair; immunotherapy; PARP inhibitors; prostate cancer;

  机译：BRCA1;BRCA2;缺陷DNA修复;免疫疗法;PARP抑制剂;前列腺癌;